Precision Health University Research Institute, Queen Mary University of London, London, UK; Department of Clinical Haematology, Royal London Hospital, Barts Health NHS Trust, London, UK
Auto-generated profile, based on publicly available information
Joseph Taylor
Precision Health University Research Institute, Queen Mary University of London, London, UK; Department of Clinical Haematology, Royal London Hospital, Barts Health NHS Trust, London, UK
There has been considerable interest in the role of the lymphoma microenvironment. Despite the use of highly active antiretroviral therapy (HAART), AIDS-related diffuse large-B-cell lymphoma remain...
We read with interest the recent paper published in Haematologica by Sasse et al . examining programmed cell death protein – 1 (PD1) expression in paired pretreatment/relapse samples for patients receiving PD1 inhibitor therapy in classical Hodgkin lymphoma (CHL).[1][1] Although the authors
Iron deficiency (ID) is a major contributor to global disease burden and the leading cause of anaemia. Early detection is important for proactive management, but conventional complete blood count (CBC) screening often fails to identify non-anaemic iron deficiency (NAID) as many individuals maintain haemoglobin and red cell indices within reference ranges. Analysing 153,565 subjects from the INTERVAL, COMPARE and STRIDES studies, we show that CBC screening has only 40.5 % sensitivity for ID detection, falling to 21.9 % for NAID, highlighting a detection gap. CBC analysers generate a wealth of data beyond Electronic Health Record CBC parameters. We demonstrate that artificial intelligence applied to single-cell flow cytometry data from the CBC analyser achieves 83.7 % sensitivity for ID and 79.3 % for NAID. Our findings show that AI can greatly improve detection of a high-prevalence, important condition without changing infrastructure or diagnostic pathways, providing a valuable tool for proactive anaemia management.